BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38143921)

  • 1. Trend Analysis of Palliative Care Utilization in Patients with Chronic Obstructive Pulmonary Disease During Hospitalization from 2007 to 2018 in Taiwan.
    Kao LT; Ko SC; Chen PJ; Wu YC; Liao KM; Liang YS; Ho CH; Liang FW
    Int J Chron Obstruct Pulmon Dis; 2023; 18():3015-3026. PubMed ID: 38143921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of Healthcare Utilization among Chronic Obstructive Pulmonary Disease Patients with and without Cancer Receiving Palliative Care: A Population-Based Study in Taiwan.
    Kao LT; Cheng KC; Chen CM; Ko SC; Chen PJ; Liao KM; Ho CH
    Int J Environ Res Public Health; 2020 Jul; 17(14):. PubMed ID: 32664347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Nationwide COPD Pay-for-Performance Program on COPD Exacerbations in Taiwan.
    Cheng SL; Li YR; Huang N; Yu CJ; Wang HC; Lin MC; Chiu KC; Hsu WH; Chen CZ; Sheu CC; Perng DW; Lin SH; Yang TM; Lin CB; Kor CT; Lin CH
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2869-2881. PubMed ID: 34703221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.
    Blanchette CM; Gutierrez B; Ory C; Chang E; Akazawa M
    J Manag Care Pharm; 2008 Mar; 14(2):176-85. PubMed ID: 18331119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using the BODE Index and Comorbidities to Predict Health Utilization Resources in Chronic Obstructive Pulmonary Disease.
    Li CL; Lin MH; Chen PS; Tsai YC; Shen LS; Kuo HC; Liu SF
    Int J Chron Obstruct Pulmon Dis; 2020; 15():389-395. PubMed ID: 32110007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based study.
    Ho TW; Tsai YJ; Ruan SY; Huang CT; Lai F; Yu CJ;
    PLoS One; 2014; 9(12):e114866. PubMed ID: 25490399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Performance of Comorbidity Measures in Predicting Health Outcomes in Patients with Chronic Obstructive Pulmonary Disease.
    Zhan ZW; Chen YA; Dong YH
    Int J Chron Obstruct Pulmon Dis; 2020; 15():335-344. PubMed ID: 32103932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity of ICD9-CM codes to diagnose chronic obstructive pulmonary disease from National Health Insurance claim data in Taiwan.
    Ho TW; Ruan SY; Huang CT; Tsai YJ; Lai F; Yu CJ
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3055-3063. PubMed ID: 30323577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of antidiabetic medications and risk of chronic obstructive pulmonary disease exacerbation requiring hospitalization: a disease risk score-matched nested case-control study.
    Wang MT; Lai JH; Huang YL; Kuo FC; Wang YH; Tsai CL; Tu MY
    Respir Res; 2020 Dec; 21(1):319. PubMed ID: 33267895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk assessment of readmissions following an initial COPD-related hospitalization.
    Baker CL; Zou KH; Su J
    Int J Chron Obstruct Pulmon Dis; 2013; 8():551-9. PubMed ID: 24348031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health Care Resource Utilization and Exacerbation Rates in Patients with COPD Stratified by Disease Severity in a Commercially Insured Population.
    Wallace AE; Kaila S; Bayer V; Shaikh A; Shinde MU; Willey VJ; Napier MB; Singer JR
    J Manag Care Spec Pharm; 2019 Feb; 25(2):205-217. PubMed ID: 30698096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. End-of-Life Health Care Utilization Between Chronic Obstructive Pulmonary Disease and Lung Cancer Patients.
    Kuo LC; Chen JH; Lee CH; Tsai CW; Lin CC
    J Pain Symptom Manage; 2019 May; 57(5):933-943. PubMed ID: 30708124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population.
    Schwab P; Dhamane AD; Hopson SD; Moretz C; Annavarapu S; Burslem K; Renda A; Kaila S
    Int J Chron Obstruct Pulmon Dis; 2017; 12():735-744. PubMed ID: 28260880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population.
    Pasquale MK; Sun SX; Song F; Hartnett HJ; Stemkowski SA
    Int J Chron Obstruct Pulmon Dis; 2012; 7():757-64. PubMed ID: 23152680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic burden of comorbidities among COPD Patients hospitalized for acute exacerbations: an analysis of a commercially insured population.
    Shah CH; Onukwugha E; Zafari Z; Villalonga-Olives E; Park JE; Slejko JF
    Expert Rev Pharmacoecon Outcomes Res; 2022 Jun; 22(4):683-690. PubMed ID: 34530664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden of asthma and COPD overlap (ACO) in Taiwan: a nationwide population-based study.
    Shantakumar S; Pwu RF; D'Silva L; Wurst K; Kuo YW; Yang YY; Juan YC; Chan KA
    BMC Pulm Med; 2018 Jan; 18(1):16. PubMed ID: 29368608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes risks and outcomes in chronic obstructive pulmonary disease patients: Two nationwide population-based retrospective cohort studies.
    Lin CS; Liu CC; Yeh CC; Chang YC; Chung CL; Lane HL; Shih CC; Chen TL; Liao CC
    PLoS One; 2017; 12(8):e0181815. PubMed ID: 28813433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prompt initiation of triple therapy following hospitalization for a chronic obstructive pulmonary disease exacerbation in the United States: An analysis of the PRIMUS study.
    Evans KA; Pollack M; Portillo E; Strange C; Touchette DR; Staresinic A; Patel S; Tkacz J; Feigler N
    J Manag Care Spec Pharm; 2022 Dec; 28(12):1366-1377. PubMed ID: 36427341
    [No Abstract]   [Full Text] [Related]  

  • 19. End-of-life care in individuals with respiratory diseases: a population study comparing the dying experience between those with chronic obstructive pulmonary disease and lung cancer.
    Kendzerska T; Nickerson JW; Hsu AT; Gershon AS; Talarico R; Mulpuru S; Pakhale S; Tanuseputro P
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1691-1701. PubMed ID: 31534323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
    Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.